BIOND BIOLOGICS LTD has a total of 12 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are PROGASTRINE ET CANCERS S A R L, GO THERAPEUTICS INC and WUXI BIOLOGICS IRELAND LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Sapir Yair | 11 |
#2 | Hakim Motti | 11 |
#3 | Alishekevitz Dror | 11 |
#4 | Shulman Avidor | 11 |
#5 | Meilin Edna | 10 |
#6 | Haves Ziv Dana | 9 |
#7 | Mandel Ilana | 8 |
#8 | Ben-Moshe Tehila | 7 |
#9 | Fridman-Dror Anna | 2 |
#10 | Goldshtein Ilana | 1 |
Publication | Filing date | Title |
---|---|---|
WO2021028921A1 | Antibodies against ilt2 and use thereof | |
WO2020183473A1 | Small shedding blocking agents | |
WO2020183471A1 | A method for immunosuppression | |
CN112074539A | Methods and compositions for reducing the soluble immunoreceptor CD28 |